DrugPatentWatch Database Preview
Drugs in Development Information for Manidipine
» See Plans and Pricing
What is the development status for investigational drug Manidipine?
Manidipine is an investigational drug.
There have been 4 clinical trials for Manidipine.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 20th 2015.
The most common disease conditions in clinical trials are Hypertension, Diabetes Mellitus, Type 2, and Diabetes Mellitus. The leading clinical trial sponsors are Chiesi Farmaceutici S.p.A., Mario Negri Institute for Pharmacological Research, and Korea University Guro Hospital.
There are nine hundred and twenty-seven US patents protecting this investigational drug and eight international patents.
Summary for Manidipine
| US Patents | 927 |
| International Patents | 8,790 |
| US Patent Applications | 1,680 |
| WIPO Patent Applications | 2,227 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2015-08-20) |
| Vendors | 70 |
Recent Clinical Trials for Manidipine
| Title | Sponsor | Phase |
|---|---|---|
| Manidipine Versus Amlodipine in Patients With Hypertension | Takeda Pharmaceuticals International, Inc. | Phase 4 |
| Manidipine Versus Amlodipine in Patients With Hypertension | Korea University Guro Hospital | Phase 4 |
| Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment | Servicio Gallego de Salud | Phase 4 |
Clinical Trial Summary for Manidipine
Top disease conditions for Manidipine
Top clinical trial sponsors for Manidipine
US Patents for Manidipine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Manidipine | Start Trial | Combination therapy | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Manidipine | Start Trial | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Start Trial |
| Manidipine | Start Trial | Ultra-pure agonists of guanylate cyclase C, method of making and using same | SYNERGY PHARMACEUTICALS, INC. (New York, NY) | Start Trial |
| Manidipine | Start Trial | Fused heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Manidipine | Start Trial | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Tokyo, JP) | Start Trial |
| Manidipine | Start Trial | Treatment for diabetes in patients inappropriate for metformin therapy | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Manidipine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Manidipine | Australia | AU2011249722 | 2030-05-05 | Start Trial |
| Manidipine | Brazil | BR112012028136 | 2030-05-05 | Start Trial |
| Manidipine | Canada | CA2797310 | 2030-05-05 | Start Trial |
| Manidipine | Canada | CA3070513 | 2030-05-05 | Start Trial |
| Manidipine | Chile | CL2012003053 | 2030-05-05 | Start Trial |
| Manidipine | China | CN102946875 | 2030-05-05 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
